Bricanyl 500 micrograms/ml solution for injection or infusion आयरलैंड - अंग्रेज़ी - HPRA (Health Products Regulatory Authority)

bricanyl 500 micrograms/ml solution for injection or infusion

astrazeneca ab - terbutaline sulfate - solution for injection/infusion - 500 microgram(s)/millilitre - selective beta-2-adrenoreceptor agonists; terbutaline

Bricanyl Turbohaler 500 micrograms per metered dose, inhalation powder आयरलैंड - अंग्रेज़ी - HPRA (Health Products Regulatory Authority)

bricanyl turbohaler 500 micrograms per metered dose, inhalation powder

astrazeneca ab - terbutaline sulfate - inhalation powder - 500 mcg/acutuation - selective beta-2-adrenoreceptor agonists; terbutaline

Bricanyl Turbohaler 500 micrograms per metered dose, inhalation powder. माल्टा - अंग्रेज़ी - Medicines Authority

bricanyl turbohaler 500 micrograms per metered dose, inhalation powder.

astrazeneca ab se-151 85, södertälje, sweden - inhalation powder - terbutaline sulfate 500 µg/spray - drugs for obstructive airway diseases

Nuelin-SR न्यूज़ीलैंड - अंग्रेज़ी - Medsafe (Medicines Safety Authority)

nuelin-sr

inova pharmaceuticals (new zealand) limited - theophylline 250mg;  ; theophylline 250mg - modified release tablet - 250 mg - active: theophylline 250mg   excipient: cellacefate lactose monohydrate magnesium stearate active: theophylline 250mg excipient: guar gum magnesium stearate - nuelin-sr tablets are indicated for the relief and prophylaxis of reversible bronchospasm associated with asthma, chronic bronchitis and emphysema.

BRICANYL TURBUHALER POWDER (METERED DOSE) कनाडा - अंग्रेज़ी - Health Canada

bricanyl turbuhaler powder (metered dose)

astrazeneca canada inc - terbutaline sulfate - powder (metered dose) - 0.5mg - terbutaline sulfate 0.5mg - selective beta 2-adrenergic agonists

PULMICORT RESPULES budesonide 0.25mg/mL inhalation ampoule ऑस्ट्रेलिया - अंग्रेज़ी - Department of Health (Therapeutic Goods Administration)

pulmicort respules budesonide 0.25mg/ml inhalation ampoule

astrazeneca pty ltd - budesonide, quantity: 0.25 mg/ml - inhalation, conventional - excipient ingredients: disodium edetate; sodium chloride; polysorbate 80; citric acid; sodium citrate dihydrate; water for injections - treatment of bronchial asthma. indications as approved 15 july 1997: treatment of bronchial asthma. pulmicort may also be used when replacement or reduction in oral steroid therapy is desirable. treatment of acute laryngotracheobronchitis (croup) in infants and children.